QuidelOrtho Corp. Hits Day Low of $11.63 Amid Price Pressure

QuidelOrtho Corp., a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced significant volatility today, with the stock hitting an intraday low of USD 11.63. This decline is part of a broader trend, as the company has reported a staggering loss of 27.47% in its one-day performance, contrasting sharply with the S&P 500's modest gain of 0.26%. Over the past week, QuidelOrtho has seen a decrease of 10.35%, and its performance over the last month reflects a decline of 28.13%. Year-to-date, the stock has plummeted by 55.58%, and its one-year performance shows a staggering drop of 49.8%. The three-year and five-year performance metrics are equally concerning, with losses of 86.53% and 90.15%, respectively. The company's financial health is under scrutiny, highlighted by a high debt-equity ratio of 138.72% and a low interest coverage ratio of 142.31. Additionally, QuidelOrtho has reported negative results for the last 12 consecutive quarters, indicating ongoing challenges in its operational performance. As it stands, the stock's performance continues to lag behind the S&P 500, raising questions about its market position and future viability.